1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → HCID 90408866、化合物
反応式
[Cl:1][C:2]1[C:3]2[CH2:11][CH2:10][N:9]([C:12]([C:14]3[CH:19]=[CH:18][CH:17]=[C:16]([C:20]([F:23])([F:22])[F:21])[C:15]=3[Cl:24])=[O:13])[CH2:8][C:4]=2[N:5]=[CH:6][N:7]=1.ClC1C(C(F)(F)F)=CC=CC=1C(O)=O.CCN=C=NCCCN(C)C.[CH:50]1[CH:51]=[CH:52][C:53]2[N:58]([OH:59])[N:57]=[N:56][C:54]=2[CH:55]=1>C(Cl)Cl.CCOC(C)=O>[Cl:1][C:2]1[C:3]2[CH2:11][CH2:10][N:9]([C:12]([C:14]3[CH:19]=[CH:18][CH:17]=[C:16]([C:20]([F:23])([F:21])[F:22])[C:15]=3[Cl:24])=[O:13])[CH2:8][C:4]=2[N:5]=[CH:6][N:7]=1.[N:58]1([O:59][C:2]2[C:3]3[CH2:11][CH2:10][N:9]([C:12]([C:14]4[CH:19]=[CH:18][CH:17]=[C:16]([C:20]([F:23])([F:22])[F:21])[C:15]=4[Cl:24])=[O:13])[CH2:8][C:4]=3[N:5]=[CH:6][N:7]=2)[C:53]2[CH:52]=[CH:51][CH:50]=[CH:55][C:54]=2[N:56]=[N:57]1参加物
反応物 4
生成物 2
試薬・触媒・溶媒 2
実験手順
To a solution of the product of Intermediate 3 step a (305 mg, 1.80 mmol) in DCM (9 mL) was added 2-chloro-3-(trifluoromethyl)benzoic acid (404 mg, 1.80 mmol) followed by EDCI (517 mg, 2.70 mmol), HOBt (170 mg, 1.26 mmol) and TEA (0.50 mL, 3.60 mmol). The mixture was stirred overnight and then loaded directly on a column. Chromatography on SiO2 eluting with EtOAc/Hex afforded the desired product (267 mg, 39%) and 4-(1H-benzotriazol-1-yloxy)-7-{[2-chloro-3-(trifluoromethyl)phenyl]carbonyl}-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine (203 mg, 24%) as a side product. MS (ESI) mass calcd. C15H10Cl2F3N3O, 375.02. m/z found 376.0 [M+H]+. 1H NMR (500 MHz, CDCl3): 8.89-8.74 (m, 1H), 7.84-7.76 (m, 1H), 7.55-7.45 (m, 2H), 5.13-4.94 (m, 1H), 4.54-4.35 (m, 1H), 4.23-4.06 (m, 1H), 3.64-3.52 (m, 1H), 3.10-2.78 (m, 2H).
出典と根拠
- ORDレコード
- ord-400618ce05d04a238c40fd347dc6d2a1
- 出典データセット
- uspto-grants-2015_08
- 特許番号
- US09096596B2
反応ノート
読み込み中…